Last Updated:
Name Designation Appointment Date Status
Venkata Subba Siva Prakash Vinayakula

Appointed as Director since June 2015

Director 08-Jun-2015 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dhanalakshmamma Vinayakula

Appointed as Director since June 2015

Director 08-Jun-2015 Current

People Timeline

Explore the timeline of key personnel in Nemsis Pharmaceuticals (I) Private Limited's leadership journey.

Loading...
Contact Details
  • Address H No. 78/129/B1, Old No. 109/130, Krishna Nagar, Kurnool Andhra Pradesh, 518002, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 518002
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Nemsis Pharmaceuticals (I) Private Limited?
You can contact Nemsis Pharmaceuticals (I) Private Limited through their registered address at H No. 78/129/B1, Old No. 109/130, Krishna Nagar, Kurnool Andhra Pradesh, 518002, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Nemsis Pharmaceuticals (I) Private Limited?
The current directors of Nemsis Pharmaceuticals (I) Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • VENKATA SUBBA SIVA PRAKASH VINAYAKULA
  • DHANALAKSHMAMMA VINAYAKULA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available